Periodic Reporting for period 1 - ATRS Instrument (Real time analysis of tablet and capsule dosage during pharmaceutical manufacturing)
Reporting period: 2015-04-01 to 2015-09-30
By avoiding the use of solvents and other consumables TRS can reduce environmental impact of testing. Cost reductions and work in progress reductions have a significant benefit to the cost of manufacture, which impacts the cost of drugs on the market – particularly generic products which have a lower profit margin than those on patent. This is an area that is not well exploited and has the potential to improve the testing process. For Pharma manufacturing on-line or at-line testing, TRS can replace many HPLC instruments, reduce staff resource in QC and streamline manufacturing in high volume production.